These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3804902)

  • 1. Treatment of respiratory tract infections with ciprofloxacin.
    Raoof S; Wollschlager C; Khan F
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():139-45. PubMed ID: 3804902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled, comparative study of ciprofloxacin versus ampicillin in treatment of bacterial respiratory tract infections.
    Wollschlager CM; Raoof S; Khan FA; Guarneri JJ; LaBombardi V; Afzal Q
    Am J Med; 1987 Apr; 82(4A):164-8. PubMed ID: 3555030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential intravenous-oral administration of ciprofloxacin vs ceftazidime in serious bacterial respiratory tract infections.
    Khan FA; Basir R
    Chest; 1989 Sep; 96(3):528-37. PubMed ID: 2670465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ciprofloxacin in the treatment of respiratory infections. Analysis of an Italian series].
    Maggiolo F; Bianchi W; Ohnmeiss H
    G Ital Chemioter; 1988; 35(1-3):39-44. PubMed ID: 3256511
    [No Abstract]   [Full Text] [Related]  

  • 5. Ciprofloxacin: an update on clinical experience.
    Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Becker N; August R
    Am J Med; 1987 Apr; 82(4A):381-6. PubMed ID: 3555063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of ciprofloxacin in the treatment of UTIs and RTIs in patients affected by liver diseases.
    Esposito S; Galante D; Barba D; Bianchi W; Gagliardi R; Giusti R
    Infection; 1988; 16 Suppl 1():S57-61. PubMed ID: 3286517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, safety, and potential economic benefits of oral ciprofloxacin in the treatment of infections.
    Sanders WE
    Rev Infect Dis; 1988; 10(3):528-43. PubMed ID: 3293158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized study comparing low dose ciprofloxacin and ofloxacin in the treatment of lower respiratory tract infections.
    Polubiec A; Jórasz I; Pietrzak J; Soszka A; Stepka K; Zaryn A
    Infection; 1994; 22(1):62-4. PubMed ID: 8181847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of ciprofloxacin in patients with respiratory infections in comparison with amoxycillin.
    Gleadhill IC; Ferguson WP; Lowry RC
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():133-8. PubMed ID: 3804901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of temafloxacin versus ciprofloxacin in lower respiratory tract infections: a randomized, double-blind trial.
    Lindsay G; Scorer HJ; Carnegie CM
    J Antimicrob Chemother; 1992 Jul; 30(1):89-100. PubMed ID: 1331020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of the new quinolones in lower respiratory infections.
    Davies BI; Maesen FP
    Chemioterapia; 1987 Jun; 6(2 Suppl):447-8. PubMed ID: 3509469
    [No Abstract]   [Full Text] [Related]  

  • 12. Ciprofloxacin. A review of its pharmacological profile and therapeutic use in the elderly.
    Wiseman LR; Balfour JA
    Drugs Aging; 1994 Feb; 4(2):145-73. PubMed ID: 8186542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ciprofloxacin by the intravenous route in the treatment of respiratory infections].
    Mangiarotti P; Manara G; Bianchi L; Piccioni PD; Grassi C
    G Ital Chemioter; 1989; 36(1-3):89-94. PubMed ID: 2488917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Campoli-Richards DM; Monk JP; Price A; Benfield P; Todd PA; Ward A
    Drugs; 1988 Apr; 35(4):373-447. PubMed ID: 3292209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral ciprofloxacin treatment of infections in geriatric patients.
    Yangco BG; Kenyon VS; Halkias KD; Bogel JA; Toney JF; Chmel H
    Clin Ther; 1989; 11(4):503-10. PubMed ID: 2776166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of ciprofloxacin in the treatment of patients with respiratory tract infections in Japan.
    Kobayashi H
    Am J Med; 1987 Apr; 82(4A):169-73. PubMed ID: 3555031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral ciprofloxacin versus intravenous therapy with other non-quinolone agents: a study of 291 infections.
    Lorian V; Pavletich K
    Drugs Exp Clin Res; 1994; 20(5):209-14. PubMed ID: 7875058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The efficacy and tolerance of Bay-o-9867 (ciprofloxacin) in the treatment of infections of the urinary tract and of the lower respiratory tract].
    Quartieri F; Bolognesi S; Sconosciuto F
    Recenti Prog Med; 1994 Feb; 85(2):96-100. PubMed ID: 8184195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of oral ciprofloxacin in the treatment of respiratory tract infections associated with chronic hepatitis.
    Esposito S; Galante D; Bianchi W; Gagliardi R
    Am J Med; 1987 Apr; 82(4A):211-4. PubMed ID: 3555038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of ciprofloxacin in bacterial infections of the respiratory and gastrointestinal tract].
    Sforza E; De Gennaro M; Ruggieri A; Ninno D; Pastore G
    Riv Eur Sci Med Farmacol; 1988 Dec; 10(6):533-7. PubMed ID: 3274737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.